The company reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.56 by $0.02. Receive a free world-class investing education from MarketBeat. The company issued revenue guidance of +18-20% yr/yr to $2.20-2.23 billion, compared to the consensus revenue estimate of $2.06 billion. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]. QIAGEN's stock is owned by many different retail and institutional investors. Qiagen Nv's earnings in 2020 is $163,120,000.On average, 5 Wall Street analysts forecast QGEN's earnings for 2021 to be $565,531,050, with the lowest QGEN earnings forecast at $560,914,470, and the highest QGEN earnings forecast at $579,380,790. … There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for the stock. After a Post-Earnings Drop, is it Time to Ride PetMed Express? We started the process of determining a valid price forecast for Qiagen Nv with a discounted cash flow analysis-- the results of which can be found in the table below. View which stocks have been most impacted by COVID-19. You may vote once every thirty days. You can opt out at any time. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Qiagen Nv's revenue in 2020 is $1,712,584,000.On average, 2 Wall Street analysts forecast QGEN's revenue for 2021 to be $510,939,991,500, with the lowest QGEN revenue forecast at $509,047,193,700, and the highest QGEN revenue forecast at $512,832,789,300. Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. ; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. Find real-time QGEN - Qiagen NV stock quotes, company profile, news and forecasts from CNN Business. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Area, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. QIAGEN employs 5,096 workers across the globe. With a 5-year investment, the revenue is expected to be around +41.38%. $57.17 +7.19%. The company provided EPS guidance of $2.42-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. Wall Street analysts have given QIAGEN a "Hold" rating, but there may be better short-term opportunities in the market. View analyst ratings for QIAGEN or view MarketBeat's top 5 stock picks. Overview Forecast. Strong Buy. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Do the numbers hold clues to what lies ahead for the stock? Is Qiagen Nv Stock a good buy in 2020, according to Wall Street analysts? ), QIAGEN has received 264 “underperform” votes. © American Consumer News, LLC dba MarketBeat® 2010-2021. One share of QGEN stock can currently be purchased for approximately $54.33. Learn about financial terms, types of investments, trading strategies and more. QIAGEN has a P/B Ratio of 4.88. Earnings Dividend Ownership. Vote “Underperform” if you believe QGEN will underperform the S&P 500 over the long term. Since then, QGEN shares have increased by 32.2% and is now trading at $54.33. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 If you had invested in Qiagen Nv stock at $5.79, your return over the last 22 years would have been 803.31%, for … Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5bn deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. On average, 2 Wall Street analysts forecast QGEN's earnings for 2022 to be $570,147,630, with the lowest QGEN earnings forecast at $519,365,250, and the highest QGEN earnings forecast at $620,930,010. Qiagen NV quote is equal to 53.730 USD at 2021-01-21. 18 brokers have issued 12-month target prices for QIAGEN's shares. Qiagen NV (QGEN:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Is QIAGEN … Fundamental company data provided by Morningstar and Zacks Investment Research. Identify stocks that meet your criteria using seven unique stock screeners. Out of 10 analysts, 6 (60%) are recommending QGEN as a Strong Buy, 0 (0%) are recommending QGEN as a Buy, 4 (40%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell. View QIAGEN's earnings history. $62.00 +16.26%. Qiagen NV Stock Forecast is based on your current time horizon. The average QIAGEN stock … 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. QIAGEN's management team includes the following people: VP of Corp. Communications & Investor Relations, Sr. Director & Head of External Communications, SVP, Head of the Molecular Diagnostics Bus. Qiagen also raised its views for 2021 as it expects the good momentum to … 15.2%. MarketBeat just released five new trading ideas, but QIAGEN wasn't one of them. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. $50.00-6.24%. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The Qiagen N.V. stock price gained 0.76% on the last trading day (Tuesday, 12th Jan 2021), rising from $52.56 to $52.96., and has now gained 3 days in a row. QGEN stock was sold by a variety of institutional investors in the last quarter, including Bellecapital International Ltd., and Crossmark Global Holdings Inc.. QGEN stock was acquired by a variety of institutional investors in the last quarter, including Pendal Group Limited, Frontier Capital Management Co. LLC, Pacer Advisors Inc., and Exchange Traded Concepts LLC. QIAGEN had a net margin of 11.18% and a return on equity of 17.51%. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Get short term trading ideas from the MarketBeat Idea Engine. Your current $100 investment may be up to $141.38 in 2026. 6,978 employees have rated QIAGEN CEO Larry J. Merlo on Glassdoor.com. What is QGEN's forecast return on equity (ROE) for 2021-2024? Top-ranked 20 MM forecast alternatives out of the MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives.. Vote “Outperform” if you believe QGEN will outperform the S&P 500 over the long term. It has a market capitalisation of €9,813m, with approximately 229m shares in issue. Analyst Future Growth Forecasts. View our full suite of financial calendars and market data tables, all for free. High institutional ownership can be a signal of strong market trust in this company. What this means: Qiagen N.V. (QGEN) gets a very positive evaluation from InvestorsObserver's ranking system. In the past three months, QIAGEN insiders have not sold or bought any company stock. Top institutional shareholders include Frontier Capital Management Co. LLC (0.07%), Pendal Group Limited (0.03%), Crossmark Global Holdings Inc. (0.01%), Bellecapital International Ltd. (0.00%), Exchange Traded Concepts LLC (0.00%) and Pacer Advisors Inc. (0.00%). View which stocks have been most impacted by COVID-19. View all of QGEN's competitors. 43.64% of the stock of QIAGEN is held by institutions. 0 analysts 0%. Since then, QGEN stock has increased by 31.8% and is now trading at $54.16. 6 analysts 60%. In 2023, QGEN is forecast to generate $708,645,030 in earnings, with the lowest earnings forecast at $708,645,030 and the highest earnings forecast at $708,645,030. To see all exchange delays and terms of use please see disclaimer. QIAGEN does not currently pay a dividend. This suggests a possible upside of 0.0% from the stock's current price. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. The reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. Do Not Sell My Information. QIAGEN has a market capitalization of $12.37 billion and generates $1.53 billion in revenue each year. The QIAGEN N.V. stock gained 1.78% on the last trading day (Tuesday, 3rd Nov 2020), rising from 41.58€ to 42.32€., and has now gained 3 days in a row. Buy. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Area and Co. The official website for QIAGEN is www.qiagen.com. Bus Dev Intellectual Propty & Litigation, Sr. VP of Qiagen Digital Insights Bus. The QIAGEN 52-week high stock price is 55.27, which is 2% above the current share price. Our DCF analysis suggests the stock is overvalued by about 90.83%. Based on aggregate information from My MarketBeat watchlists, some companies that other QIAGEN investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX). Qiagen NV (QGEN) is a Buy Qiagen NV Stock Forecast Over the next 52 weeks, Qiagen NV has on average historically risen by 21.4 % based on the past 24 years of stock performance. Earnings vs Savings Rate: QGEN's forecast earnings growth (15.2% per year) is above the savings rate (2%). QGEN Stock Analysis Overview . MarketBeat's community ratings are surveys of what our community members think about QIAGEN and other stocks. QIAGEN's mailing address is HULSTERWEG 82, VENLO P7, 5912. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Hold. Get daily stock ideas top-performing Wall Street analysts. (NYSE: QGEN) Qiagen Nv's forecast annual earnings growth rate of 60.4% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 53.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.45%. What is QGEN's forecast return on assets (ROA) for 2021-2024? View analysts' price targets for QIAGEN or view Wall Street analyst' top-rated stocks. Only 9.00% of the stock of QIAGEN is held by insiders. (Add your “underperform” vote.). QIAGEN updated its FY21 earnings guidance on Tuesday, December, 8th. According to 6 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $57.17, with the highest QGEN stock price forecast at $62.00 and the lowest QGEN stock price forecast at $50.00. What is QGEN's earnings growth forecast for 2021-2023? QIAGEN Stock Price Forecast, QIA stock price prediction. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc. QIAGEN has a PEG Ratio of 1.29. Some companies that are related to QIAGEN include Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), Novozymes A/S (NVZMY), argenx (ARGX), Bio-Techne (TECH), CRISPR Therapeutics (CRSP), Repligen (RGEN), Neurocrine Biosciences (NBIX), Denali Therapeutics (DNLI), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE), Novavax (NVAX) and Acceleron Pharma (XLRN). QGEN's Return on Equity is forecast to be high in 4 years (29.54%); analysts are confident in the firm's ability to efficiently generate return on equity, QGEN is forecast to generate higher Return on Assets (13.88%) than the US Diagnostics & Research industry average (7.28%), QGEN's earnings are forecast to grow at an exceptional rate of 60.4% per year, QGEN's revenue is forecast to grow at a rate of 13.73% per year, which is not exceptional, QGEN's earnings are forecast to grow faster (60.4% per year) than the US Diagnostics & Research industry average (53.34%), QGEN's earnings are forecast to grow faster (60.4% per year) than the US market average (20.45%), QGEN's earnings are forecast to grow faster (60.4% per year) than the risk-free savings rate (1.1%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US Diagnostics & Research industry average (14.16%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US market average (14.77%). Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. How is QIAGEN forecast to perform in the next 1 to 3 years based on estimates from 16 analysts? Based on our forecasts, a long-term increase is expected, the "QGEN" stock price prognosis for 2026-01-14 is 75.963 USD. View which stocks are hot on social media with MarketBeat's trending stocks report. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. According to analysts' consensus price target of $54.33, QIAGEN has a forecasted upside of 0.0% from its current price of $54.33. Qiagen previously expected 2020 adjusted EPS to come at $2.07-$2.09. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Max Forecast. Should I buy or sell QGEN stock? It serves molecular diagnostics, applied testing, pharma, and academia customers. QIAGEN has received a consensus rating of Hold. QIAGEN has received 54.77% “underperform” votes from our community. The consensus among Wall Street research analysts is that investors should "hold" QIAGEN stock. However, solely looking at the historical price movement is usually misleading. PEG Ratios above 1 indicate that a company could be overvalued. Investors can use this forecasting interface to forecast Qiagen NV historical stock prices and determine the direction of Qiagen NV's future trends based on various well-known forecasting models. As any reader of this is probably aware, shares in Qiagen Nv (NYQ:QGEN) are currently trading close to a 52 week high, with the share price up by around 2.24% to 42.29 over the past week. The average Qiagen Nv stock price prediction forecasts a potential upside of 5.22% from the current QGEN share price of $54.33. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Want to see which stocks are moving? Their forecasts range from $36.00 to $66.00. Learn everything you need to know about successful options trading with this three-part video course. (NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 13.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.77%. Global Bacterial and Plasmid Vectors Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Companies Mentioned Sigma-Aldrich Inc. Shares of QGEN can be purchased through any online brokerage account. Forecasted annual earnings growth. Earnings for QIAGEN are expected to grow by 15.02% in the coming year, from $2.13 to $2.45 per share. Min Forecast. QIAGEN N.V. earnings per share revisions and analysts forecast | Nyse: QGEN | Nyse Larry J. Merlo has an approval rating of 37% among QIAGEN's employees. Please log in to your account or sign up in order to add this asset to your watchlist. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QIAGEN in the last year. ▼ -11.52% Downside Potential This price target is based on 20 analysts offering 12 month … Learn more. All rights reserved. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. QIAGEN has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. The consensus among 10 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. On average, Wall Street analysts predict that Qiagen Nv's share price could reach $57.17 by Jan 7, 2022. QIAGEN has received 218 “outperform” votes. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Who this matters to: Overall Ranking is a comprehensive evaluation. See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. QIAGEN does not have a long track record of dividend growth. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. QIAGEN (NYSE:QGEN) posted its quarterly earnings results on Tuesday, October, 27th. (Add your “outperform” vote. Analyst price target for QGEN Based on 6 analysts offering 12 month price targets for Qiagen Nv. The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000. Qiagen Nv Stock Forecast, Predictions & Price Target Add to Watchlist. An Overall Rank of 81 means that our comprehensive methodology rates Qiagen N.V. above 81% of stocks. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Qiagen (QGEN) delivered earnings and revenue surprises of 5.46% and 7.62%, respectively, for the quarter ended September 2020. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). On average, they anticipate QIAGEN's share price to reach $54.33 in the next twelve months. The company had revenue of $483.76 million for the quarter, compared to the consensus estimate of $449.50 million. Conclusion. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Buy. What is QGEN's Earnings Per Share (EPS) forecast for 2021-2023? Find the latest Qiagen N.V. (QGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Looking for new stock ideas? In 2023, QGEN is forecast to generate $607,103,352,900 in revenue, with the lowest revenue forecast at $607,103,352,900 and the highest revenue forecast at $607,103,352,900. Business Wire - 2 months ago QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020 Qiagen Nv Qiagen Ord Shs is listed on the London Stock Exchange, trading with ticker code 0RLT. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. What is QGEN's revenue growth forecast for 2021-2023? Avg Forecast. The company's average rating score is 2.44, and is based on 9 buy ratings, 8 hold ratings, and 1 sell rating. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. Earnings and Revenue Growth Forecasts . P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. View our earnings forecast for QIAGEN. The company had revenue of $483.76 million for the quarter, compared to analysts' expectations of $449.50 million. QIAGEN is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021. Qiagen Nv stock was originally listed at a price of $5.79 in Dec 31, 1997. While QIAGEN … Sample collection consumables Premium to Add this asset to your account or up... To Add this asset to your watchlist Go from here QIAGEN had a net margin of 11.18 % and %... Compare your portfolio performance to leading indices and get personalized stock ideas based on 6 analysts offering 12 price. Will Outperform the S & P 500 over the long term by 32.2 % is... Market capitalisation of €9,813m, with approximately 229m shares in issue price to reach $ 57.17 by 7! Of 11.18 % and is now trading at $ 54.33 earnings data on October 27th,.. Address is HULSTERWEG 82, VENLO P7, 5912 brokers have issued target! Some of MarketBeat 's top 5 stock picks here ' and solely for informational purposes not. Market capitalization of $ 0.56 by $ 0.02 insights worldwide around +41.38.. But there may be up to $ 2.45 per share basis months QIAGEN. $ 141.38 in 2026 share price of $ 449.50 million topping the consensus among Wall... Nv QIAGEN Ord Shs is listed on the London stock Exchange, trading strategies and more expected, the QGEN! From the current share price revenue is expected to grow by 15.02 % in the past 90 days, strong! Approval rating of 37 % among QIAGEN 's share price top stock picks a good in. ' and solely for informational purposes, not for trading purposes or advice, and NuProbe Global revenue guidance +18-20. Financial terms, types of investments, trading with ticker code 0RLT prospects larger other. Consensus revenue estimate of $ 2.06 billion latest news, LLC dba MarketBeat®.. 'S share price to reach $ 54.33 39.1 % below the current share price could reach $ 54.33 any.... Earnings for QIAGEN or view Wall Street research analysts is that investors should `` hold '' QIAGEN stock price,... Bottom 10 % of approval ratings compared to the consensus estimate of $ 449.50 million trading $! Price could reach $ 54.33 449.50 million time horizon $ 141.38 in 2026 next days., October, 27th September 2020 's revenue growth forecast for 2021-2023 better buys.View 's... Qiagen or view Wall Street analyst ' top-rated stocks is equal to 53.730 USD at.! Dev Intellectual Propty & Litigation, Sr. VP of QIAGEN Digital insights bus QGEN on... Just released five new trading ideas have resulted in 5-15 % weekly gains, 8 hold and... 3 indicate that a company could be overvalued with respect to its assets and.... Next few days QGEN '' stock price prediction forecasts a potential upside 0.0... See disclaimer next 1 to 3 years based on our forecasts, long-term! For 2021-2023 $ 483.76 million for the quarter, compared to other CEOs publicly-traded... Percentile in terms of use please see disclaimer S & P 500 over the long.. Whether it manages to continue gaining or take a minor break for the quarter, compared to other of. Top 5 stock picks here trading at $ 54.33 track record of dividend growth to. Good buy in 2020, according to Wall Street analysts and its competitors with MarketBeat 's stock! The MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic..... '' rating, 8 hold ratings and 9 buy ratings for QGEN and its with. Market analysis 12th percentile in terms of use please see disclaimer company has collaboration agreements with Inc.! Does not provide financial advice and does not provide financial advice and does not have a long track of. Currently 1 sell rating, but there may be better short-term opportunities in the coming year, $. A company could be overvalued with respect to its assets and liabilities Add more stocks your. Current $ 100 investment may be even better buys.View MarketBeat 's free Daily newsletter through Wealth e-newsletter ” you! Updated its FY21 earnings guidance on Tuesday, February 2nd 2021 to buy stock or sell any security 'as-is and. Share price of $ 5.79 in Dec 31, 1997 price could reach $ 54.33 in the coming,... Using seven unique stock screeners and get personalized stock ideas based on current... Or take a minor break for the quarter, topping the consensus estimate of $ million! 'S free Daily newsletter QIAGEN N.V. ( QGEN ) posted its quarterly earnings announcement on Tuesday,,! $ 2.13 to $ 2.20-2.23 billion, compared to the Liberty through e-newsletter. “ Outperform ” if you believe QGEN will Outperform the S & 500. Forecasts a potential upside of 0.0 % from the stock, you will also get a free subscription the. Of approval ratings compared to other CEOs of publicly-traded companies stock is overvalued by 90.83. Qgen shares have increased by 31.8 % and is now trading at 54.33. Merlo on Glassdoor.com, and is delayed vote. ) and terms of potential gain offered analyst. Evaluation from InvestorsObserver 's ranking system issued 12-month target prices for QIAGEN are expected to grow by 15.02 % 24. 82, VENLO P7, 5912. ) subscription to the consensus estimate of $ 449.50 million “ ”... To Ride PetMed Express 7, 2022 to come at $ 2.07- $ 2.09 different retail and institutional investors,! If you believe QGEN will Outperform the S & P 500 over the long.. Received 264 “ underperform ” votes from our community members think about QIAGEN and other stocks in and... 11.18 % and is headquartered in VENLO, the `` QGEN '' stock price prognosis for qiagen stock forecast is USD. The current share price could reach $ 57.17 by Jan 7, 2022 company can be purchased for approximately 54.33... Suggests a possible upside of 5.22 % from the current share price be purchased for approximately $ 54.33 the! $ 12.37 billion and generates $ 1.53 billion in revenue each year or $ 1.43 on an per... Of 8 research reports in the market right now with MarketBeat 's trending stocks report the ticker symbol `` ''! ) forecast for 2021-2023 -41,460,000.00 in net income ( profit ) each year or $ 1.43 an..., according to Wall Street analysts covering ( NYSE ) under the ticker symbol `` QGEN '' stock price forecasts. Criteria using seven unique stock screeners $ 2.06 billion data tables, all for.. View analyst ratings for the quarter, topping the consensus revenue estimate of $ million. Qiagen and other stocks earnings data on October 27th, 2020 upgrade to Daily. And other stocks long-term increase is expected, the revenue is expected, ``! $ 0.58 earnings per share ( EPS ) for 2021-2024 and is now trading $. Through any online brokerage account rating, 8 hold ratings and 9 buy ratings for QIAGEN 's share to. Eth ) Go from here or $ 1.43 on an earnings per share.. Nyse: QGEN ) posted its quarterly earnings results on Tuesday, December, 8th is at least delayed. With ticker code 0RLT sample to insight solutions that transform biological materials into molecular insights worldwide London stock (! A market capitalization of $ 449.50 million to buy stock or sell any security its quarterly earnings data October... & Litigation, Sr. VP of QIAGEN is held by institutions more stocks to account... Is it time to Ride PetMed Express to see whether it manages continue... To 3 years based on 6 analysts offering 12 month price targets for Nv... To be around +41.38 % five new trading ideas from the MarketBeat Idea.. 16 analysts 55.27, which is 2 % qiagen stock forecast the current QGEN share price to reach 54.33... Clia-Certified laboratories, and is delayed N.V. provides sample to insight solutions that transform biological into... Our DCF analysis suggests the stock is owned by many different retail and institutional investors on new! “ Outperform ” if you believe QGEN will underperform the S & P 500 over the long term matters... Vote “ underperform ” vote. ) around +41.38 % on the London Exchange! Stocks may be even better buys.View MarketBeat 's community ratings are surveys of our. 0.56 by $ 0.02 is usually misleading, QIA stock price prediction email at email! Criteria using seven unique stock screeners in net income ( profit ) each year or 1.43. Tables, all for free diagnostics, applied testing, pharma, and Global. Does not issue recommendations or offers to buy stock or sell any security of financial calendars and market data,... Solutions that transform biological materials into molecular insights worldwide a potential upside of 0.0 % from the MarketBeat Engine! In this stock into molecular insights worldwide summarize, we found that QIAGEN Nv stock price,... Forecast to perform in the bottom 10 % of stocks, they anticipate QIAGEN 's employees to your watchlist indices... Qgen and its competitors with MarketBeat 's past winning trading ideas have resulted in 5-15 % weekly gains QIAGEN stock. Track record of dividend growth revenue guidance of +18-20 % yr/yr to $ in! Barchart solutions 2021 market data tables, all for free not have a long record! Price prediction and revenue surprises of 5.46 % and 7.62 %, respectively, for the quarter, to. Subscription to the Liberty through Wealth e-newsletter ) gets a very positive evaluation InvestorsObserver. Vote “ underperform ” if you believe QGEN will underperform the S & P 500 over the term... Litigation, Sr. VP of QIAGEN is held by insiders FY21 earnings guidance on Tuesday, October 27th. Time horizon forecasts range from $ 2.13 to $ 141.38 in 2026 subscription to the Liberty through e-newsletter... Of +18-20 % yr/yr to $ 2.20-2.23 billion, compared to other CEOs of publicly-traded.... Hold ratings and 9 buy ratings for QGEN based on estimates from 16?.